Most drug-delivery systems (DDS) suffer from poor selectivity to cancer/normal cells or the complicated synthetic process. Herein, we employed a novel facile method to develop an oligodeoxy nucleotides based DDS composed with adenosine-5′- triphosphate (ATP) aptamer and a pH responsive cytosine (C) DNA fragment for specific daunomycine (DNM) delivery. The DDS has ATP/pH dual-responsive drug release, can selectively internalize into tumor cell lines and thus has ultrahigh cancer/normal cell selectivity over the individual drug. The non-chemical synthesis, controllable dual-responsive intracellular drug release, and high cancer/normal cell selectivity endowed the DDS high biocompatibility and significant tumor suppression.
YuWLiuRZhouY, et al.Size-tunable strategies for a tumor targeted drug delivery system. ACS Cent Sci2020; 6: 100–116.
2.
ZhangZXiaoCYongT, et al.Cellular microparticles for tumor targeting delivery: from bench to bedside. Chem Commun2020; 56: 6171–6188.
3.
JoyeeEBPanY. Additive manufacturing of multi-material soft robot for on-demand drug delivery applications. J Manufacturing Process2020; 56: 1178–1184.
4.
HuangGHuangH. Application of hyaluronic acid as carriers in drug delivery. Drug Deliv2018; 25: 766–772.
5.
WangLLiJXiongY, et al.Ultrashort peptides and hyaluronic acid-based injectable composite hydrogels for sustained drug release and chronic diabetic wound healing. ACS Appl Mater Inter2021; 13: 58329–58339.
6.
LuZ-RQiaoP, et al.Drug delivery in cancer therapy, quo vadis?Mol Pharmaceutics2018; 15: 3603–3616.
7.
LiYLiuJ, et al.Aptamer-based strategies for recognizing adenine, adenosine, ATP and related compounds. The Analyst2020; 145: 6753–6768.
8.
ZhangFHuangP-JJLiuJ, et al.Sensing adenosine and ATP by aptamers and gold nanoparticles: opposite trends of color change from domination of target adsorption instead of aptamer binding. ACS Sensors2020; 5: 2885–2893.
9.
SrivastavaPHiraSKSrivastavaDN, et al.ATP-decorated mesoporous silica for biomineralization of calcium carbonate and P2 purinergic receptor-mediated antitumor activity against aggressive lymphoma. ACS Appl Mater Inter2018; 10: 6917–6929.
10.
LiuYYangGZouD, et al.Formulation of nanoparticles using mixing-induced nanoprecipitation for drug delivery. Ind Eng Chem Res2020; 59: 4134–4149.
11.
FengGLuoXLuX, et al.Engineering of nucleic acids and synthetic cofactors as holo sensors for probing signaling molecules in the cellular membrane microenvironment. Angew Chem Int Edition2019; 58: 6590–6594.
12.
ChowdhuriARSinghTGhoshSK, et al.Carbon dots embedded magnetic nanoparticles @chitosan @metal organic framework as a nanoprobe for pH sensitive targeted anticancer drug delivery. ACS Appl Mater Inter2016; 8: 16573–16583.
13.
HuQLiHWangL, et al.DNA nanotechnology-enabled drug delivery systems. Chem Rev2019; 119: 6459–6506.
14.
YaoCYuanYYangD. Magnetic DNA nanogels for targeting delivery and multistimuli-triggered release of anticancer drugs. ACS Appl Bio Mater2018; 1: 2012–2020.
15.
WangSLiuFLiX-L. Monitoring of “on-demand” drug release using dual tumor marker mediated DNA-capped versatile mesoporous silica nanoparticles. Chem Commun2017; 53: 8755–8758.
16.
SunX-YLiuM-CChenX-L, et al.A dual-targeted nucleic acid moiety decorated SPION nanoparticles for chemo-photodynamic synergistic therapy. J Lumin2019; 209: 387–397.
17.
SunXLiuBChenX, et al.Aptamer-assisted superparamagnetic iron oxide nanoparticles as multifunctional drug delivery platform for chemo-photodynamic combination therapy. J Mater Sci Mater Med2019; 30: 76–91.
18.
HuiYYiXHouF, et al.Role of nanoparticle mechanical properties in cancer drug delivery. ACS Nano2019; 13: 7410–7424.
19.
WenJYangKLiuF, et al.Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems. Chem Soc Rev2017; 46: 6024–6045.
20.
SciclunaMCVella-ZarbL, et al.Evolution of Nanocarrier Drug-Delivery Systems and Recent Advancements in Covalent Organic Framework-Drug Systems. ACS Appl Nano Mater2020; 3: 3097–3115.
21.
TjandraKCThordarsonP, et al.Multivalency in drug delivery-when is it too much of a good thing?Bioconjug Chem2019; 30: 503–514.
22.
KnopKHoogenboomRFischerD, et al.Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives. Angew Chem Int Edition2010; 49: 6288–6308.
23.
KhalidMEl-SawyHS. Polymeric nanoparticles: promising platform for drug delivery. Int J Pharm2017; 528: 675–691.
24.
JiangH-LIslamMAXingL, et al.Degradable polyethylenimine-based gene carriers for cancer therapy. Top Curr Chem2017; 375: 34–42.
25.
KuangYZhaiJXiaoQ, et al.Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review. Int J Biol Macromolecules2021; 193: 457–473.
26.
SameiyanEBagheriEDehghaniS, et al.Aptamer-based ATP-responsive delivery systems for cancer diagnosis and treatment. Acta Biomater2021; 123: 110–122.
27.
WangHChenYShangJ, et al.Multifunctional hypoxia-involved gene silencing nanoplatform for sensitizing photochemotherapy. ACS Appl Mater Inter2020; 12: 34588–34598.
28.
LiaoJHuangH. Review on magnetic natural polymer constructed hydrogels as vehicles for drug delivery. Biomacromolecules2020; 21: 2574–2594.
29.
ElhamADizajSMSiminS, et al.The potential of nanomaterials in theranostics of oral squamous cell carcinoma: Recent progress. Trac-trend Anal Chem2019; 116: 167–176.
30.
EftekhariAMaleki DizajSAhmadianE, et al.Application of advanced nanomaterials for kidney failure treatment and regeneration. Materials2021; 14: 2939–2957.
31.
VardaSYakovKQuanC. VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis. Curr Med Chem2017; 24: 4435–4446.
32.
DeboraGLucaZTaniaC. Mitochondria in cancer. Cell Stress2020; 4: 114–146.
33.
LiuJLiuWYangH. Balancing Apoptosis and Autophagy for Parkinson's Disease Therapy: Targeting BCL-2. ACS Chem Neurosci2019; 10: 792–802.
34.
ZhouXChenLNieW, et al.Dual-responsive mesoporous silica nanoparticles mediated codelivery of doxorubicin and Bcl-2 siRNA for targeted treatment of breast cancer. The J Phys Chem C2016; 120: 22375–22387.
35.
MennaPSalvatorelliEMinottiG. Cardiotoxicity of Antitumor Drugs†. Chem Res Toxicol2008; 21: 978–989.
36.
ZhangBWanSPengX, et al.Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity. J Mater Chem B2020; 8: 3939–3948.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
